Osteosarcoma

Osteosarcoma is a malignant bone tumor predominantly affecting adolescents and young adults. Recent cancer research focuses on understanding its genetic and molecular underpinnings to develop targeted therapies. Advances in genomics have identified key mutations and pathways, such as the RB1 and TP53 genes, involved in tumor development. Immunotherapy, particularly the use of immune checkpoint inhibitors, is being explored to enhance the body's immune response against osteosarcoma cells. Additionally, researchers are investigating the tumor microenvironment to identify new therapeutic targets. Despite challenges, these efforts aim to improve prognosis and survival rates for osteosarcoma patients through precision medicine and novel treatment strategies.